Midline Market Size, Share, & Trends Analysis | Global | 2026-2032 | MedCore | Includes: MST and AST Midlines

Year: 2026
Scope: 10 Years
Region: Global
Published Date: 12/31/2025
Type: MedCore

Product Description

The global midline market was valued at around $192 million in 2025. This is expected to increase over the forecast period at a CAGR of 3.5% to reach $245 million by 2032.

The full report suite on the global market for midlines includes the accelerated Seldinger technique (AST) and modified Seldinger technique (MST) segments. The MST midline is further categorized into power-injectable and non-power-injectable.

The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.

Data Types Included

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
Market Drivers & Limiters
Market Forecasts Until 2032, and Historical Data to 2022
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

Midlines Market Trends

Global Midline Market Growth, 2022-2033

Demographic pressures and rising inpatient volumes continue to shift vascular access practices toward midlines. An aging global population and higher hospitalization rates are increasing demand for intermediate-duration intravenous access. Patients who would previously have received PICCs, or repeated PIVC placements, are increasingly managed with midline catheters to balance safety, dwell time and procedural efficiency. This structural shift in care pathways continues to underpin long-term growth in midline utilization.

Midlines Market Share Insights

Top Global Midline Market Leaders

Becton Dickinson (BD) offers a diverse range of midline products, including the PowerGlide® line and others, holding a significant share of the power-injectable AST midline market. BD stands out as it covers all midline segments. It provides older non-power-injectable options such as Groshong® Midline Catheter and Per-Q-Cath® Midline Catheter. The PowerMidline™, PowerGlide ST™, PowerGlide® and PowerGlide Pro™ cater to various lengths and configurations for AST insertions. Unlike competitors, BD midlines lack premium features such as antimicrobial or antithrombogenic properties, leading to standard ASPs.
Teleflex ranks second in the midline market, offering a broad portfolio of midline catheter kits, including basic and maximal barrier precaution kits. Its Arrowg+ard Blue Advance™ Midline, U.S. Food and Drug Administration (FDA)-approved in 2016, uses chlorhexidine coating for antimicrobial properties, commanding a price premium due to its unique features.
AngioDynamics entered the midline market in 2015 with BioFlo® Midline Catheters, which are power-injectable and designed to prevent thrombus buildup. In February 2024, AngioDynamics announced the sale of its PICC and midline product portfolios to Spectrum Vascular. BioFlo® midlines are power-injectable and are designed to reduce thrombus accumulation. The company has incorporated BioFlo® technology into many of its vascular access devices, such as PICCs, ports and dialysis catheters. BioFlo® technology has experienced significant growth in many product areas in recent years. With this acquisition, Spectrum Vascular aims to strengthen its presence in the vascular access market and expand its product offerings.

Midlines Market Segmentation Summary

Midline Market – Further Segmented Into:
- Device Type: MST (Power-Injectable & Non-Power Injectable) and AST

Research Scope Summary

Report Attribute	Details
Regions	North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year	2025
Forecast	2026-2032
Historical Data	2022-2024
Quantitative Coverage	Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage	Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources	Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

CONTACT US FOR ADDITIONAL INFORMATION

For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.

FREE Sample Report

11.1 Executive Summary

11.1.1 Global Midline Market Overview

11.1.2 Competitive Analysis

11.1.3 Procedures Included

11.1.4 Markets Included

11.1.5 Regions Included

11.2 Introduction

11.3 Procedure Numbers

11.3.1 Total Midline Procedures

11.4 Market Overview

11.4.1 By Segment

11.4.2 By Region

11.5 Market Analysis and Forecast

11.5.1 Total Midline Market

11.5.2 MST Midline Market

11.5.2.1 Power-Injectable MST Midline Market

11.5.2.2 Non-Power-Injectable MST Midline Market

11.5.3 AST Midline Market

11.6 Drivers and Limiters

11.6.1 Market Drivers

11.6.2 Market Limiters

11.7 Competitive Market Share Analysis

Companies Included

· Adhezion Biomedical	· Matz Medical
· Applied Medical Technology	· Medical Plastic Devices Inc.
· AngioDynamics	· Medcomp
· Argon Medical	· Medicina
· B. Braun	· Medikit
· Baxter International	· Medline
· Becton Dickinson	· MedSource
· BioLife	· Medtronic
· Bionic	· Menarini
· Cambridge Sensors	· Merit Medical
· Cardinal Health	· Mermaid Medical
· Catheter Connections	· Micsafe Med
· Centurion Medical	· MPS Medical
· Codan	· Multimedical
· Cook Medical	· NeedleBay
· Deltamed	· Neo Medical
· DeRoyal	· Neon Diagnostics
· Districlass Medical	· Nipro Medical
· Exel International	· Nova Medical
· Fannin	· Novico
· Fresenius	· Owen Mumford Inc.
· GlucoRx	· Pentaferte
· Greiner Bio-One	· PFM Medical
· Health Line Medical Products	· Polimed
· HEKA Healthcare	· Prosum Medical
· Hollister Incorporated	· Rays
· HTL-STREFA	· Retractable Technologies
· ICU Medical	· Roche
· IME-DC	· Sentra Medical
· Interrad Medical	· SFM
· Johnson & Johnson	· Smith & Nephew
· Joline	· Solventum
· Kawasumi	· Spectrum Vascular
· Kimal	· SPRINT MOTO
· Klinion	· Trinity Sterile
· Marvao Medical	· Troge
· Matz Medical	· V-Tech
· M.C. Johnson	· Vortex
· Marvao Medical	· Vygon
	· Ypsomed

Chart List

Chart 11‑1: Midline Market, Global, 2023 & 2030

Chart 11‑2: Midline Procedures, Global, 2023

Chart 11‑3: Midline Procedures by Region, Global, 2020 – 2030

Chart 11‑4: Midline Market by Segment, Global, 2020 – 2030

Chart 11‑5: Midline Market by Region, Global, 2020 – 2030

Chart 11‑6: Leading Competitors, Midline Market, Global, 2023

Figure List

Figure 11‑1: Midline Procedures Covered

Figure 11‑2: Midline Markets Covered

Figure 11‑3: Midline Regions Covered, Global (1 of 2)

Figure 11‑4: Midline Regions Covered, Global (2 of 2)

Figure 11‑5: Midline Procedures by Region, Global, 2020 – 2030

Figure 11‑6: Midline Procedures by Country, North America, 2020 – 2030

Figure 11‑7: Midline Procedures by Country, Latin America, 2020 – 2030 (1 of 2)

Figure 11‑8: Midline Procedures by Country, Latin America, 2020 – 2030 (2 of 2)

Figure 11‑9: Midline Procedures by Country, Western Europe, 2020 – 2030

Figure 11‑10: Midline Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)

Figure 11‑11: Midline Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)

Figure 11‑12: Midline Procedures by Country, Middle East, 2020 – 2030

Figure 11‑13: Midline Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)

Figure 11‑14: Midline Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)

Figure 11‑15: Midline Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)

Figure 11‑16: Midline Procedures by Country, Africa, 2020 – 2030

Figure 11‑17: Midline Market by Segment, Global, 2020 – 2030 (US$M)

Figure 11‑18: Midline Market by Region, Global, 2020 – 2030 (US$M)

Figure 11‑19: Midline Market, Global, 2020 – 2030

Figure 11‑20: Units Sold by Region, Midline Market, Global, 2020 – 2030

Figure 11‑21: Average Selling Price by Region, Midline Market, Global, 2020 – 2030 (US$)

Figure 11‑22: Market Value by Region, Midline Market, Global, 2020 – 2030 (US$M)

Figure 11‑23: MST Midline Market by Segment, Global, 2020 – 2030 (US$M)

Figure 11‑24: Total MST Midline Market, Global, 2020 – 2030

Figure 11‑25: Units Sold by Region, MST Midline Market, Global, 2020 – 2030

Figure 11‑26: Average Selling Price by Region, MST Midline Market, Global, 2020 – 2030 (US$)

Figure 11‑27: Market Value by Region, MST Midline Market, Global, 2020 – 2030 (US$M)

Figure 11‑28: Power-Injectable MST Midline Market, Global, 2020 – 2030

Figure 11‑29: Units Sold by Region, Power-Injectable MST Midline Market, Global, 2020 – 2030

Figure 11‑30: Average Selling Price by Region, Power-Injectable MST Midline Market, Global, 2020 – 2030 (US$)

Figure 11‑31: Market Value by Region, Power-Injectable MST Midline Market, Global, 2020 – 2030 (US$M)

Figure 11‑32: Non-Power-Injectable MST Midline Market, Global, 2020 – 2030

Figure 11‑33: Units Sold by Region, Non-Power-Injectable MST Midline Market, Global, 2020 – 2030

Figure 11‑34: Average Selling Price by Region, Non-Power-Injectable MST Midline Market, Global, 2020 – 2030 (US$)

Figure 11‑35: Market Value by Region, Non-Power-Injectable MST Midline Market, Global, 2020 – 2030 (US$M)

Figure 11‑36: AST Midline Market, Global, 2020 – 2030

Figure 11‑37: Units Sold by Region, AST Midline Market, Global, 2020 – 2030

Figure 11‑38: Average Selling Price by Region, AST Midline Market, Global, 2020 – 2030 (US$)

Figure 11‑39: Market Value by Region, AST Midline Market, Global, 2020 – 2030 (US$M)

Figure 11‑40: Leading Competitors, Midline Market, Global, 2023

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

Original primary research that consists of the most up-to-date market data
Strong foundation of quantitative and qualitative research
Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Report Options

Report Summary

FREE

Select License Type

Overall, the global midline market was valued at $187 million in 2023. This is expected to increase over the forecast period at a CAGR of 5.2% to reach $267 million.